home / stock / rhhbf / rhhbf news


RHHBF News and Press, Roche Holding Ltd From 06/14/24

Stock Information

Company Name: Roche Holding Ltd
Stock Symbol: RHHBF
Market: OTC

Menu

RHHBF RHHBF Quote RHHBF Short RHHBF News RHHBF Articles RHHBF Message Board
Get RHHBF Alerts

News, Short Squeeze, Breakout and More Instantly...

RHHBF - Structure Therapeutics: Yet Another Potential GLP-1 Entrant

2024-06-14 10:24:55 ET Summary Structure Therapeutics Inc. shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R clinical rivals. However, GSBR-1290's efficacy at week 12 fell below Novo Nordisk's amycretin, but still competitive in the obesity treatm...

RHHBF - CDC worried about 'dual mutant' flu strains resistant to antiviral meds

2024-06-14 09:21:38 ET More on Roche Roche Is Joining The Obesity Party But Questions Remain Emerging Leaders: Roche And Viking Therapeutics In The Obesity Treatment Race Roche: Targeting Mega-Money Obesity Markets After Sharing Stunning Weight Loss Data Nova...

RHHBF - Sarepta gains after Pfizer's late-stage setback for Duchenne therapy

2024-06-13 07:00:26 ET More on Pfizer, Roche, etc. Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Pfizer: Surging Cancer Rates ...

RHHBF - Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better

2024-06-11 08:37:32 ET Summary Affimed's 06/01/24 update on AFM24 means the company has a second viable commercial asset.  This is why the stock popped after ASCO. Acimtamig's update is due before the end of this month.  If it is positive, the stock should run again for ...

RHHBF - AstraZeneca dominates, Merck's Keytruda beaten as ASCO 2024 concludes

2024-06-08 10:19:36 ET More on AstraZeneca, Bristol-Myers, etc. Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript) Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84% Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly ...

RHHBF - Novartis, Roche facing Italy antitrust probe over Lucentis biosimilar

2024-06-06 07:09:15 ET More on Novartis, Roche, etc. Novartis AG (NVS) Investor Event at ASCO Conference Call (Transcript) Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Roche Is Joining The Obesity Party But Questions Remain SA Asks: Which weight-lo...

RHHBF - Harding Loevner International Developed Markets Equity Composite Q1 2024 Report

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHBF - Harding Loevner International Equity ADR Composite Q1 2024 Report

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHBF - Harding Loevner International Equity Composite Q1 2024 Report

2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

RHHBF - Parnassus Core Equity Fund Q1 2024 Investment Commentary

2024-05-26 04:30:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

Previous 10 Next 10